Janux Therapeutics Inc.

NASDAQ: JANX
Share price (3/25/25): $30.83
Market cap (3/25/25): $1.822 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Ra Capital Management, L.P.

RA Capital Healthcare Fund LP, Ra Capital Management, L.P., Kolchinsky Peter, Shah Rajeev M., RA Capital Nexus Fund II, L.P.

Meyer Andrew Hollman

Meyer Andrew Hollman

Janus Henderson Group plc

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Announces Proposed Public Offering

Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

Reports Third Quarter 2024 Financial Results and Business Highlights

Reports Second Quarter 2024 Financial Results and Business Highlights

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC